ANI PHARMACEUTICALS INC — Director's Dealing 2016

May 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2016-05-06

Reporting Person: CAREY STEPHEN P. (Vice President and CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-06	Option to Purchase	$46.49	A	50000	Acquired	2026-05-05	Common Stock (50000)	Direct

Footnotes

F1: The options vest in an equal annual amount over a four-year period beginning on the first anniversary of the grant date.